Acarbose C₂₅H₄₃NO₁₈

Therapeutic indications

Acarbose is indicated for:

Diabetes mellitus

Population group: both men and women, only adults (18 years old or older)

Acarbose is recommended for the treatment of non-insulin dependent (NIDDM) diabetes mellitus in patients inadequately controlled on diet alone, or on diet and oral hypoglycaemic agents.

For this indication, competent medicine agencies globally authorize below treatments (click for details):

Contraindications

Acarbose is contraindicated in the following cases:

Severe renal impairment

at least one of
Renal failure stage 5: Kidney failure (GFR <15 mL/min/1.73 m2 or dialysis)

Severe hepatic impairment

Hepatic failure stage IV

Inflammatory bowel disease, intestinal obstruction

at least one of
Inflammatory bowel disease (disorder)
Intestinal obstruction (disorder)

Pregnancy

Pregnancy

Breastfeeding

Lactation

Get recommendations

Factors such as age, gender, and health history are evaluated to create a personalized medication regimen.

Ask the Reasoner

Related medicines

Summary of Product Characteristics (SPC) 2017: GLUCOBAY 100mg Tablets
Summary of Product Characteristics (SPC) 2017: GLUCOBAY 50mg Tablet
< Previous: Overview
Next: Precautions >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.

⇈